Growth of Children With Cerebral Palsy and Health Outcomes

Richard D Stevenson1, Mark R Conaway1, Gordon Worley2

  • 1University of Virginia, Charlottesville, Virginia.

Pediatrics
|March 18, 2026
PubMed

Insights

The cerebral palsy (CP) growth charts are validated for assessing health markers beyond mortality. Lower weight percentiles correlate with increased hospitalizations and reduced social participation in children with CP.

Area of Science:

  • Pediatric endocrinology
  • Growth and development in children with disabilities
  • Clinical assessment tools for cerebral palsy

Background:

  • Cerebral palsy (CP) growth charts from California (2011) linked Gross Motor Function Classification System (GMFCS)-stratified weight percentile (GWt%-ile) to mortality.
  • Clinical use of these charts has been limited.
  • The North American Growth in Cerebral Palsy Project (NAGCPP) provides data to further evaluate these charts.

Purpose of the Study:

  • To validate the California CP growth charts using NAGCPP data.
  • To assess the association between GWt%-ile and health markers beyond mortality.
  • To explore the role of triceps skinfold thickness (TSF) and comorbidities.

Main Methods:

  • Secondary analysis of NAGCPP data including 197 boys and 146 girls (2-18 years) with CP (GMFCS III-V).
  • Weight and TSF data were collected; health care utilization and social participation assessed via questionnaire.
  • GWt%-ile determined using sex and GMFCS-specific charts; 20th percentile cutoff used to assess relationships.

Main Results:

  • NAGCPP weight data demonstrated good fit with the CP growth charts (P > 0.14).
  • Children below the 20th GWt%-ile had significantly higher hospitalizations (5.7x), missed programs (3.1x), and missed activities (2.8x).
  • TSF (fat stores) and severe feeding problems were independently associated with health and participation outcomes.

Conclusions:

  • The study validates the CP growth charts for use in clinical settings.
  • GWt%-ile is associated with key health and participation markers in children with CP, extending beyond mortality.
  • CP growth charts are recommended for clinical decision-making and research.
Abstract